180 related articles for article (PubMed ID: 25985706)
1. Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma.
Shah NJ; Vinod Kumar S; Gurusamy U; Annan Sudarsan AK; Shewade DG
J Asthma; 2015 Oct; 52(8):755-62. PubMed ID: 25985706
[TBL] [Abstract][Full Text] [Related]
2. Relationship between polymorphisms in the 5' leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China.
Fu WP; Zhao ZH; Zhong L; Sun C; Fang LZ; Liu L; Zhang JQ; Wang L; Shu JK; Wang XM; Dai LM
Respirology; 2011 Nov; 16(8):1221-7. PubMed ID: 21801278
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of the influence of ADRB2 genetic polymorphisms on albuterol (salbutamol) therapy in patients with asthma.
Hikino K; Kobayashi S; Ota E; Mushiroda T; Urayama KY; Kobayashi T
Br J Clin Pharmacol; 2021 Apr; 87(4):1708-1716. PubMed ID: 32986886
[TBL] [Abstract][Full Text] [Related]
4. Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population.
Bandaru S; Tarigopula P; Akka J; Marri VK; Kattamuri RK; Nayarisseri A; Mangalarapu M; Vinukonda S; Mundluru HP; Sagurthi SR
Gene; 2016 Oct; 592(1):15-22. PubMed ID: 27450915
[TBL] [Abstract][Full Text] [Related]
5. ADRB2 Polymorphism and Salbutamol Responsiveness in Northern Indian Children with Mild to Moderate Exacerbation of Asthma.
Sahi PK; Shastri S; Lodha R; Gupta N; Pandey RM; Kabra SK; Kabra M
Indian Pediatr; 2016 Mar; 53(3):211-5. PubMed ID: 27029682
[TBL] [Abstract][Full Text] [Related]
6. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
7. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
8. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
[TBL] [Abstract][Full Text] [Related]
9. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
[TBL] [Abstract][Full Text] [Related]
11. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
12. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
13. Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.
Konno S; Makita H; Hasegawa M; Nasuhara Y; Nagai K; Betsuyaku T; Hizawa N; Nishimura M
Pharmacogenet Genomics; 2011 Nov; 21(11):687-93. PubMed ID: 21881540
[TBL] [Abstract][Full Text] [Related]
14. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
15. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
16. Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics.
Kotani Y; Nishimura Y; Maeda H; Yokoyama M
J Asthma; 1999 Oct; 36(7):583-90. PubMed ID: 10524541
[TBL] [Abstract][Full Text] [Related]
17. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.
Yancey SW; Klotsman M; Ortega HG; Edwards LD; Anderson WH
Curr Med Res Opin; 2009 Apr; 25(4):1011-8. PubMed ID: 19275519
[TBL] [Abstract][Full Text] [Related]
19. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
[TBL] [Abstract][Full Text] [Related]
20. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
Kim SH; Ye YM; Lee HY; Sin HJ; Park HS
J Clin Pharm Ther; 2011 Jun; 36(3):399-405. PubMed ID: 21545619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
